113 related articles for article (PubMed ID: 28222509)
1. Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.
Nakayama S; Suda A; Nakanishi A; Motoi Y; Hattori N
J Alzheimers Dis; 2017; 57(1):267-273. PubMed ID: 28222509
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
3. Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.
Cummings JL; Schneider L; Tariot PN; Kershaw PR; Yuan W
Am J Psychiatry; 2004 Mar; 161(3):532-8. PubMed ID: 14992980
[TBL] [Abstract][Full Text] [Related]
4. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
Oka M; Nakaaki S; Negi A; Miyata J; Nakagawa A; Hirono N; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):121-34. PubMed ID: 26114924
[TBL] [Abstract][Full Text] [Related]
5. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
Monsch AU; Giannakopoulos P;
Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
[TBL] [Abstract][Full Text] [Related]
6. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
[TBL] [Abstract][Full Text] [Related]
7. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
Mega MS; Dinov ID; Porter V; Chow G; Reback E; Davoodi P; O'Connor SM; Carter MF; Amezcua H; Cummings JL
Arch Neurol; 2005 May; 62(5):721-8. PubMed ID: 15883258
[TBL] [Abstract][Full Text] [Related]
8. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
[TBL] [Abstract][Full Text] [Related]
9. Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
Pirker-Kees A; Dal-Bianco P; Schmidt R
J Alzheimers Dis; 2019; 71(2):623-630. PubMed ID: 31424389
[TBL] [Abstract][Full Text] [Related]
10. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
Hashimoto M; Yatabe Y; Kaneda K; Honda K; Ikeda M
Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821
[TBL] [Abstract][Full Text] [Related]
11. Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease.
Uflacker A; Edmondson MC; Onyike CU; Appleby BS
Int Psychogeriatr; 2016 Feb; 28(2):269-73. PubMed ID: 26435062
[TBL] [Abstract][Full Text] [Related]
12. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].
Hirono N; Kobayashi H; Mori E
No To Shinkei; 1998 Jun; 50(6):561-7. PubMed ID: 9656252
[TBL] [Abstract][Full Text] [Related]
13. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
[TBL] [Abstract][Full Text] [Related]
14. Galantamine and behavior in Alzheimer disease: analysis of four trials.
Kavanagh S; Gaudig M; Van Baelen B; Adami M; Delgado A; Guzman C; Jedenius E; Schäuble B
Acta Neurol Scand; 2011 Nov; 124(5):302-8. PubMed ID: 21615354
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients.
Keller C; Kadir A; Forsberg A; Porras O; Nordberg A
J Alzheimers Dis; 2011; 24(1):109-23. PubMed ID: 21157026
[TBL] [Abstract][Full Text] [Related]
16. [Behavioral and psychological symptoms, cognitive impairment and caregiver burden related to Alzheimer's disease patients treated in an outpatient memory clinic].
Takechi H; Yamada H; Sugihara Y; Kita T
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):207-16. PubMed ID: 16683655
[TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
[TBL] [Abstract][Full Text] [Related]
18. Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.
Rockwood K; Fay S; Song X; MacKnight C; Gorman M;
CMAJ; 2006 Apr; 174(8):1099-105. PubMed ID: 16554498
[TBL] [Abstract][Full Text] [Related]
19. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
Gauthier S; Loft H; Cummings J
Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study.
Dauphinot V; Delphin-Combe F; Mouchoux C; Dorey A; Bathsavanis A; Makaroff Z; Rouch I; Krolak-Salmon P
J Alzheimers Dis; 2015; 44(3):907-16. PubMed ID: 25374109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
